[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
Acute Myeloid Leukemia Podcasts

HealthTree Podcasts for Acute Myeloid Leukemia features in-depth interviews with Acute Myeloid Leukemia experts. These programs are a deep dive into a single topic about Acute Myeloid Leukemia and help patients understand the latest in research and ongoing clinical trials.

podcasts Menin Inhibitors 101 with Dr. Joshua Zeidner

Jul 09, 2024 / 05:00PM EDT

Menin Inhibitors 101 with Dr. Joshua Zeidner

play_circle_filled

Listen to Episode

podcasts Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

Oct 05, 2022 / 01:30PM EDT

Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital

play_circle_filled

Listen to Episode

podcasts Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

Aug 24, 2022 / 11:00AM EDT

Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering

play_circle_filled

Listen to Episode

Digging Deeper Into the TP53 Mutation in AML with Rory Shallis, MD, Yale New Haven Hospital image
Digging Deeper Into the TP53 Mutation in AML with Rory Shallis, MD, Yale New Haven Hospital

Jul 14, 2022

HealthTree Podcast for AML

podcasts
Weighing FLT3 Inhibitor Options with Dr. Jane Liesveld, University of Rochester image
Weighing FLT3 Inhibitor Options with Dr. Jane Liesveld, University of Rochester

Jun 29, 2022

HealthTree Podcast for AML

podcasts
Attacking AML Cells with a New Immunotherapy Infusion with Kendra Sweet, MD, Moffitt Cancer Center image
Attacking AML Cells with a New Immunotherapy Infusion with Kendra Sweet, MD, Moffitt Cancer Center

Jun 09, 2022

HealthTree Podcast for AML

podcasts
Killing AML Cells with Magrolimab, a New Immunotherapy Option, with Dr. Joseph Jurcic image
Killing AML Cells with Magrolimab, a New Immunotherapy Option, with Dr. Joseph Jurcic

May 26, 2022

HealthTree Podcast for AML

podcasts
Targeting FLT3 Positive AML with New & Improved Therapies with Dr. Margaret Kasner image
Targeting FLT3 Positive AML with New & Improved Therapies with Dr. Margaret Kasner

Feb 07, 2022

HealthTree Podcast for AML

podcasts
AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein image
AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein

Feb 02, 2022

HealthTree Podcast for AML

podcasts
The Latest in AML Treatment Advances: Where We Are and Where We're Going with James Blachly, MD, Ohio State University image
The Latest in AML Treatment Advances: Where We Are and Where We're Going with James Blachly, MD, Ohio State University

Oct 25, 2021

HealthTree Podcast for AML

podcasts
Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital image
Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital

Sep 30, 2021

HealthTree Podcast for AML

podcasts
Progress Toward an All Oral Treatment for Newly Diagnosed Older Adults with AML with Gabriel Mannis, MD image
Progress Toward an All Oral Treatment for Newly Diagnosed Older Adults with AML with Gabriel Mannis, MD

Sep 13, 2021

HealthTree Podcast for AML

podcasts

Trending Articles

End-of-Life Care: Understanding Symptoms and AML Progression End-of-Life Care: Understanding Symptoms and AML Progression
New FDA-Designated Cell Therapy for AML, ALL, and MDS New FDA-Designated Cell Therapy for AML, ALL, and MDS
The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML The FDA Is Reviewing A New Treatment Option For Relapsed/Refractory AML
EHA 2024: Patient Outcomes from Oral Azacitidine Maintenance Therapy EHA 2024: Patient Outcomes from Oral Azacitidine Maintenance Therapy
What Are The AML Types, and How Are They Classified? What Are The AML Types, and How Are They Classified?

Upcoming Events

Track Your MDS Labs: Know where to start!

Track Your MDS Labs: Know where to start!

Jul 31 / 16:00 EDT

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie
Astellas Pharma
Servier

Follow Us

facebook instagram youtube

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811